U.S. President Donald Trump, who became ill with coronavirus, was given the experimental drug REGN-COV2, which is among the most promising drugs for this disease.
As The Guardian reports, this was stated by Oxford University Professor Peter Horby. He is involved in the program RECOVERY – British national testing methods of treatment of patients with severe coronavirus.
“In the laboratory, in the cultures of synthesized cells, there was a very strong effect against the virus … So it may be one of the most promising drugs available,” said the professor.
According to him, one dose of REGN-COV2, developed by the American biotechnology company Regeneron Pharmaceuticals, gives “prolonged protection” for four to six weeks, and it is suitable for elderly patients.
The professor also noted that REGN-COV2 has already received 400 to 500 patients, and so far no data on the danger of the drug has been received. He added that the drug will be sent next week to another 30 to 40 hospitals in the UK.
Recall that Donald Trump contracted coronavirus with his wife Melanie. The American leader informed about it on October 2.
As reported by TOP NEWS, on October 3 the head of the American state was hospitalized – he will spend the next days at the Walter Reed National Military Medical Center in the state of Maryland.